- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05282576
Effect of Neurophysiological Facilitation Techniques in Intensive Care Patients
Effect of Neurophysiological Facilitation Techniques on Functional Levels and Respiratory in Intensive Care Patients
Study Overview
Status
Intervention / Treatment
Detailed Description
The intensive care unit is a multidisciplinary unit in which patients with acute, life-threatening organ dysfunction or under risk are monitored and treated comprehensively. Advanced technology is used for follow-up and treatment in intensive care. These supports decrease the mortality rate. However, the increase length of stay in the ICU leads to higher hospital costs in addition to serious secondary pathologies. Prolonged immobilisation in the intensive care unit(ICU); causes the loss of muscle mass and strength of the patients. When the course of illness, the medical devices used, various medications, malnutrition and other reasons such as sepsis are accompanied by this immobilization, the disorder called Intensive Care Acquired Muscle Weakness (ICU-AW) occurs. This neuromuscular disorder, also causes functional impairments after ICU discharge.
Early physiotherapy intervention in ICU, has a positive effect on the symptoms frequently occur in patients. In addition to improve the functional status of the patient such as exercise capacity, muscle strength and mobilization, its increase weaning from mechanical ventilation, and decrease the length of stay in the ICU and hospital. It also provides airway clearance, reduction the work of breathing and improvement of respiratory function.
Neurophysiological facilitation of respiration is the use of proprioceptive and tactile stimulation that produce reflexive movement responses. These responses provide to increase the depth of breathing, decrease respiratory rate in patients with decreased level of consciousness. It also increase inspiratory expansion of the ribs, epigastric excursion and abdominal muscles tone. In the study conducted Kumar et al. has indicated that neurophysiological facilitation (NPF) techniques improves levels of dyspnea and oxygen saturation (spO2) in Coronavirus patients. It is very important to increase the level of oxygen saturation to rate the mortality. In NPF techniques, respectively the proprioceptors and tactile receptors in the abdominal, intercostals and spinal muscles are affected, phrenic motor neurons are stimulated, thoracic and abdominal excursions are increased and thus provide improves vital parameters.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34010
- Istinye University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinically Unstable
- Participants Over the Age of 18
- Individuals who volunteered to participate in the study or were allowed by their first-degree relatives if they were unconscious.
- Patients who are suitable for physiotherapy by the intensive care specialist.
Exclusion Criteria:
- Having coagulation disorder (INR > 1,5 platelet<50.000 mm3)
- Having neuromuscular diseases
- Having psychiatric disease or overly agitated (Richmond Agitation Sedation Scale score ≥ +2)
- Having acute stroke
- Having Raised Intracranial Pressure Syndrome symptoms
- Having cardiac and respiratory instability (Respiratory frequency > 30 breaths/min,Partial pressure of oxygen(PaO₂)< 65 mmHg , fraction of inspired oxygen(FiO₂)>%55, Diastolic blood pressure < 50 mmHg or > 200 mmHg , Systolic blood pressure < 80 mmHg or > 200 mmHg)
- Having hemodynamic instability (intropin dose > 5 mcg/kg/min)
- Fever
- Malignity
- Shock
- Patients admitted to ICU after cardiac, trauma and surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Experimental Group
We applied neurophysiological facilitation techniques in addition to conventional rehabilitation.
|
Participants allocated to the experimental group completed until discharged, neurophysiological facilitation(NPF) techniques in addition to conventional physiotherapy.
Other Names:
|
OTHER: Control Group
Critical ill patients was applied their conventional physiotherapy
|
Critical ill patients was applied their conventional physiotherapy which includes chest physiotherapy and mobilization until discharged
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Chelsea Critical Care Physical Assessment Tool
Time Frame: through study completion, an average of 5 days
|
The Chelsea Critical Care Physical Assessment Tool (CPAx) is a test used on male and female patients in the intensive care unit (ICU) to assess physical and respiratory function impairments and morbidity.
The CPAx assessment also identifies patients at risk for developing ICU-acquired complications, such as weakness and mobility decline.
The CPAx assesses 10 domains including respiratory function, cough, bed mobility, supine to sitting on edge of bed, dynamic sitting, standing balance, sit to stand, transferring bed to chair, stepping, and grip strength.
|
through study completion, an average of 5 days
|
Physical Function in Intensive Care Test
Time Frame: through study completion, an average of 5 days
|
Physical Function in Intensive Care Test(PFIT) is specifically for the patient population in the intensive care unit (ICU) who are critically ill.
This test can be used to guide exercise prescription within the ICU as well as measure functional recovery.
The PFIT-s is a battery outcome measure involving four components: sit to stand assistance, marching on the spot cadence, shoulder flexor and knee extensor strength.
The PFIT include 4 items.
|
through study completion, an average of 5 days
|
Premorbid Level of Activity Scales
Time Frame: through study completion, an average of 5 days
|
Premorbid dyspnea was scored according to the American Thoracic Society (ATS) scale.
The activities of daily living were recorded as 0 = working; 1 = independent (fully ambulatory and living without any assistance); 2 = restricted (able to live on their own and leave their homes to perform basic tasks, but severally limited in exercise ability); 3 = housebound (cannot leave their homes unassisted or leave their homes rarely, able to perform self-care but unable to do heavy chores such as house cleaning, cannot live alone, and may be institutionalized; and 4 = bedridden or wheelchair-bound
|
through study completion, an average of 5 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Heart Rate
Time Frame: During ICU stay
|
Heart rate can be quantified easily at the bedside, while preload estimation has traditionally relied on invasive pressure measurements, both central venous and pulmonary artery wedge
|
During ICU stay
|
Change in Blood Pressure
Time Frame: During ICU stay
|
BP can be measured non-invasively using a sphygmomanometer (BP cuff).
|
During ICU stay
|
Change in Oxygen saturation
Time Frame: During ICU stay
|
Pulse oximetry is the technique used to measure arterial oxygen saturation in the peripheral blood vessels
|
During ICU stay
|
Change in Respiratory Frequency
Time Frame: During ICU stay
|
The respiratory frequency is usually measured when a person is at rest and simply involves counting the number of breaths for one minute by counting how many times the chest rises.
|
During ICU stay
|
Change in Perception of Fatigue
Time Frame: During ICU stay
|
the Perception of Fatigue is was assess to used The Borg Rating of Perceived Exertion(RPE).
The Borg RPE scale is a numerical scale that ranges from 6 to 20, where 6 means "no fatigue at all" and 20 means "maximal fatigue.
|
During ICU stay
|
Change in Perception of Dyspnea
Time Frame: During ICU stay
|
the Perception of Dyspnea is was assess to used The Borg Rating of Perceived Exertion(RPE).
The Borg RPE scale is a numerical scale that ranges from 6 to 20, where 6 means "no dyspnea at all" and 20 means "maximal dyspnea'.
|
During ICU stay
|
The Functional Independence Measure
Time Frame: through study completion, an average of 5 days
|
The The Functional Independence Measure (FIM) is an 18-item instrument measuring a person's level of disability in terms of burden of care.
The FIM should be rated by the consensus opinion of a multidisciplinary team, but the evaluation is often performed by a single professional.
Each item is rated from 1 (requiring total assistance) to 7 (completely independent).
Three independent FIM scores can be generated by summing item scores: a total score (FIM total: 18 items), a motor score (FIM motor: eating, grooming, bathing, dressing - upper body, dressing - lower body, toileting, bladder management, bowel management, and transfers bed/chair/wheelchair, toilet, tub/shower, walk, stairs), and a cognitive score (FIM cognitive: auditory comprehension, verbal expression, social interaction, problem solving, and memory).
|
through study completion, an average of 5 days
|
Change in Muscle Strength
Time Frame: through study completion, an average of 5 days
|
Change in muscle strength was measured with a Digital Manual Muscle Tester.
|
through study completion, an average of 5 days
|
Change in Hand Grip Strength
Time Frame: through study completion, an average of 5 days
|
Change in Hand Grip Strength was measured with a Hydraulic Hand Dynamometer.
|
through study completion, an average of 5 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Mehmet Burak Uyaroğlu, PT,PhD, Saglik Bilimleri Universitesi
- Principal Investigator: Yasemin Çırak, Ass.Prof, Istinye University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Saglik Bilimleri Uni
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intensive Care Unit Acquired Weakness
-
University of MelbourneEnrolling by invitationICU Acquired Weakness | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit Syndrome | Post Intensive Care SyndromeAustralia
-
Universidade Federal do Rio de JaneiroHospital Universitario Pedro ErnestoNot yet recruitingIntensive Care Unit Acquired WeaknessBrazil
-
Federal University of Rio Grande do SulEnrolling by invitation
-
Medical Centre LeeuwardenCompletedCritical Illness | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit SyndromeNetherlands
-
Hospital Felix BulnesCompletedMechanical Ventilation Complication | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Intensive Care Unit Delirium | Intensive Care NeuropathyChile
-
Associate Professor Sue Berney PhD, BPTCompletedIntensive Care Unit Acquired Weakness (ICUAW)United States, Australia
-
Okan UniversityNot yet recruitingIntensive Care Unit Acquired Weakness | Intensive Care, Intubated Patient, Early Mobilization, Mobilization, Respiratory PatternTurkey
-
Bartın UnıversityZonguldak Ataturk State HospitalCompletedSleep | Intensive Care Unit Acquired Weakness | Patient ComplianceTurkey
-
Cairo UniversityRecruitingIntensive Care Unit Acquired WeaknessEgypt
-
Charles University, Czech RepublicFaculty Hospital Kralovske VinohradyRecruitingIntensive Care Unit-acquired WeaknessCzechia
Clinical Trials on NPF Group
-
Nihon Pharmaceutical Co., LtdCompleted
-
Federal Research Institute of Pediatric Hematology...Recruiting
-
Nihon Pharmaceutical Co., LtdCompleted
-
University of Sao Paulo General HospitalCompletedOsteoarthritis, Knee
-
Charite University, Berlin, GermanyDepartment of Neurology, Charité - Universitätsmedizin Berlin, Germany; Department...Unknown
-
Aqua Medical Services (Pvt) LtdCompletedLumbar Disc Herniation | Spinal Disk Injury | ProtrusionPakistan
-
Cairo UniversityCompleted
-
Al-Azhar UniversityCompleted
-
Zagazig UniversityCompleted
-
Riphah International UniversityCompleted